Pharmaceutical industry
The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society of Chemistry's magazine, Chemistry World
-
Opinion
Intergovernmental panel on chemicals, waste and pollution needs diverse input
Balancing industrial expertise against unwanted commercial influence is not easy but shouldn’t be discounted
-
Research
Ten years on, pharma industry still testing for implausible alkyl sulfonate ester contaminants
Risk assessment for potential mutagenic side-products is still required by regulatory bodies, despite lack of evidence they form during drug production
-
Business
Sarepta gene therapy deaths highlight tragic rare disease dilemma
Regulators block Duchenne muscular dystrophy treatment after fatal side-effects outweigh questionable efficacy
-
Opinion
China’s drug development charge
Reforms and state support have fuelled domestic and foreign investment in pharmaceutical
-
Webinar
Women’s health: insights in research and inclusion
Learn about the history and importance of the gender gap currently impacting women’s health sciences – Join us on 28 August
-
News
Why is a prehistoric creature still vital for the pharmaceutical industry?
Every year, horseshoe crabs are harvested for their blue blood, but alternatives are now coming through that could help protect these ancient animals
-
Business
Will HIV prevention get where it’s needed?
Gilead and its partners’ efforts to distribute generic lenacapavir could be derailed by cuts in international aid budgets
-
Opinion
Getting good at human tasks
’What do you mean you had to lock the NMR with an oscilloscope and shim the magnet by hand?’
-
Business
Fatal explosion and fire at Indian pharmaceutical ingredients plant
At least 42 dead and 25 injured at Sigachi Industries near Hyderabad
-
Business
US approves twice yearly injection to prevent HIV
Yeztugo (lenacapavir) provided near-total protection against infection in clinical trials
-
Feature
Hibernation awakens interest for drug discovery
With many different species entering torpor for a variety of reasons, scientists are looking to their sleepy secrets for ways to treat human diseases. Anthony King reports
-
Business
Sanofi to buy Blueprint Medicines for over $9 billion
Blueprint has one approved drug and enhances Sanofi’s immunology portfolio
-
Webinar
Modelling amorphous solid dispersion (ASD) release mechanisms
Learn how thermodynamic modelling and molecular simulation can help our understanding of amorphous solid dispersion
-
Opinion
Improving women’s health research will benefit everyone
Fixing the inequality is morally just, and economically sound
-
Opinion
Women are not just another confounding factor in drug development
Ignoring physiological differences between the sexes is indefensible
-
Business
Trade deals stave off Trump’s tariffs temporarily
Initial agreements with China and UK have paused trade war, but uncertainty reigns
-
Opinion
Rebuilding pharma supply chains
Multinationals are promising huge US investments, but it’s not all because of Trump’s policies
-
Opinion
In search of truth and rules
To codify and predict ever more complex phenomena is one of science’s great drivers
-
Business
Merck KGaA to buy cancer specialist SpringWorks
$3.9 billion deal boosts Merck’s pipeline as it faces patent expiries
-
Business
Gilead settles US HIV drug kickback lawsuit
Firm will pay $202 million to federal and state governments